IndraLab

Statements

Dibenziodolium inhibits NLRP3. 1 / 1

| 1

reach

"Pre-treatment for 30 min with the ROS inhibitor, diphenyleneiodonium (DPI, 10 microM, Sigma-Aldrich), substantially reduced NLRP3 and caspase-1 activation (XREF_FIG) and subsequently IL-1beta secretion in mDCs upon IN/11 infection (XREF_FIG)."

26068782

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Dibenziodolium inhibits NLRP3. 1 / 1

INDRA sources:

Databases

Reading